R&D World editors Paul Heney and Aimee Kalnoskas have their minds blown — multiple times! — in this episode, which delves into Certara’s Simcyp COVID-19 Vaccine Model, a 2021 R&D 100 Awards winner. Paul interviews Piet van der Graaf, Senior Vice President and Head of Quantitative Systems Pharmacology for Certara and learns about the genesis … Continued
In this episode, Max Williamson, a Patient Representative for the UK National Cancer Research Institute, and Karen Rowland Yeo, PhD, Senior Vice President at Certara, discuss the challenges in pediatric drug development, including accessibility issues for young people and the need for more qualitative data. Max and Karen also talk about how technology can accelerate … Continued
Dec 02, 2021 Hosts Alix Steel and Guy Johnson speak with Opinion Columnist Marcus Ashworth, BI Director of research Sam Fazeli, European Oil Team Leader James Herron, Certara CEO William Feehery, Grab Co-Founder Hooi Ling Tan
Lynne Georgopoulos, VP Regulatory Strategy, Certara describes the company’s platform to optimize pediatric drug development using biosimulation. With an eye on pediatric diseases, Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including neonates. They are also operationalizing clinical trials to be more efficient and … Continued
Moderated by Early Career Community member Emily Cicali, PharmD (University of Florida), Patrick Smith, PharmD (Certara) discusses the ample opportunities for small biotech companies that has arisen from changes in regulations. This episode is a great listen for anyone interested in pursuing opportunities in consulting! “More and more compounds are being developed outside the walls … Continued
Moderated by Early Career Community member Emily Cicali, PharmD (University of Florida), Patrick Smith, PharmD (Certara) discusses the risks and rewards with entrepreneurship in the field of clinical pharmacology and pharmacometrics. Patrick talks honestly about the mistakes made early on and the differing needs of team members who are starting a business in varying stages … Continued
Lynne Georgopoulos, NP, Vice President of Regulatory Strategy at Certara, joins the podcast to share with us her insights on pediatric drug development. She touches on the history of pediatric drug regulations, current challenges, upcoming projects and more!
Dr. Rayner is President of Certara’s Integrated Drug Development and Strategic Consulting Services. In this capacity, he supports a global team of clinical and quantitative pharmacologists, pharmacometricans, regulatory strategy and drug development scientists who create value for clients across the drug development ecosystem and ultimately accelerate patients’ access to medicines. Craig has extensive global experience … Continued
